IVF After Chemotherapy: Fertility Options for Cancer Survivors

Completing cancer treatment is a milestone that reshapes everything — including how you think about building a family. If you didn't have the opportunity to preserve eggs or embryos before treatment (or if you did and want to know what comes next), this guide walks through the fertility landscape after chemotherapy and where IVF fits into your options.

How Chemotherapy Affects Fertility

The impact of chemotherapy on ovarian function varies enormously depending on the specific drugs used, cumulative dose, duration of treatment, and the patient's age at the time of treatment. Understanding where your treatment falls on the gonadotoxicity spectrum is the starting point for any fertility discussion.

High gonadotoxicity (greatest impact): Alkylating agents (cyclophosphamide, busulfan, melphalan, procarbazine) and certain combination regimens (BEACOPP for Hodgkin lymphoma) carry the highest risk of permanent ovarian damage. These agents directly damage the resting pool of primordial follicles — the finite egg supply — in a dose-dependent manner.

Moderate gonadotoxicity: Platinum agents (cisplatin, carboplatin) and some targeted therapies have intermediate effects. Impact depends heavily on cumulative dose and combination with other agents.

Lower gonadotoxicity: Antimetabolites (5-FU, methotrexate), vinca alkaloids (vincristine), and most targeted/immunotherapy agents have relatively lower ovarian toxicity, though even these can affect fertility when combined with other agents.

Assessing Your Fertility Post-Treatment

After completing chemotherapy (and observing the recommended waiting period from your oncologist), a fertility assessment provides a clearer picture of where you stand:

• AMH level: Anti-Müllerian hormone is the best single marker of remaining ovarian reserve. Post-chemo AMH levels give an indication of how many recruitable follicles remain. AMH can take 6–12 months post-treatment to stabilize, so early measurements may be misleadingly low.
• Antral follicle count (AFC): Transvaginal ultrasound counting small antral follicles visible on the ovaries. Combined with AMH, this provides a reasonable reserve estimate.
• FSH and estradiol: Elevated FSH (above 10–12 IU/L on cycle day 3) suggests diminished reserve. This is a less sensitive marker than AMH but provides confirming data.
• Menstrual history: Return of regular menstruation after chemotherapy is encouraging but does not guarantee adequate ovarian reserve — some patients menstruate regularly with significantly depleted egg supplies.

When Can You Start IVF?

The waiting period between completing cancer treatment and beginning fertility treatment varies by cancer type, stage, and treatment protocol. Most oncologists recommend waiting 6–24 months after completing chemotherapy before attempting pregnancy, depending on the specific cancer's recurrence risk window and whether ongoing adjuvant therapy (such as tamoxifen for breast cancer) is recommended.

This waiting period is a safety measure — not a fertility optimization measure. Your fertility team and oncologist should coordinate directly to establish the appropriate timing for your specific situation.

Your Options

IVF with own eggs (if reserve remains): If post-treatment assessment shows adequate ovarian reserve (AMH >0.5 ng/mL, reasonable AFC), IVF with your own eggs is possible. Expect that response to stimulation may be lower than age-predicted — your RE will likely use aggressive protocols (high-dose gonadotropins, possibly DuoStim) to maximize yield.

Donor eggs: If chemotherapy depleted ovarian reserve to the point where own-egg IVF is unlikely to succeed (very low AMH, minimal AFC, elevated FSH), donor-egg IVF offers excellent success rates independent of your ovarian status. Your uterus — which is generally not damaged by chemotherapy — can carry a pregnancy even when the ovaries can no longer produce viable eggs.

Previously frozen eggs or embryos: If you preserved eggs or embryos before treatment, these are your strongest assets — they were frozen at your pre-treatment age and reserve level.

Gestational surrogacy: For patients whose uterus was affected by treatment (pelvic radiation, certain surgical treatments) or who have medical contraindications to pregnancy, gestational surrogacy using your own or donor eggs is an option. In Colombia, surrogacy is permitted through court precedent (Constitutional Court ruling T-968/2009).

Using Previously Preserved Eggs or Embryos

If you banked eggs or embryos before chemotherapy, the fertility treatment process is straightforward: a medicated frozen embryo transfer (FET) cycle, which involves estrogen and progesterone supplementation to prepare the uterine lining, followed by thawing and transferring your preserved embryo (or thawing eggs, fertilizing them via ICSI, culturing to blastocyst, and transferring). FET cycles are relatively simple — no stimulation injections, no retrieval — and can often be completed in 4–6 weeks.

Cancer Survivor IVF in Colombia

Colombia's fertility clinics within JCI-accredited hospital systems offer the full range of post-cancer fertility options: own-egg IVF with aggressive stimulation protocols, donor-egg programs, and FET services. The country's healthcare system, ranked #22 globally by the WHO (2000 report), provides the multidisciplinary infrastructure that cancer survivors benefit from — reproductive endocrinology working in coordination with oncology when needed.

For cancer survivors, the cost savings of IVF in Colombia can be particularly meaningful — many have already navigated significant medical expenses during treatment. Typical IVF cycle costs of $3,500–$5,500 (vs. $15,000–$22,000 in the US) and donor-egg cycles of $6,500–$9,500 (vs. $25,000–$40,000) represent substantial savings that may make multiple attempts feasible where only one would be affordable at home.

Explore Our Colombia Medical Network